Related by context. All words. (Click for frequent words.) 71 therapeutic antibodies 70 monoclonal antibodies 69 therapeutic monoclonal antibodies 67 monoclonal antibody 66 Nanobody ® 66 antibody 65 Nanobody 65 therapeutics 65 small molecule 65 RNAi therapeutic 65 humanized antibody 64 therapeutic monoclonal antibody 64 humanized monoclonal antibody 64 cancer immunotherapies 64 Cellzome 64 preclinical 64 JAK3 63 mAb 63 antisense drugs 63 siRNA therapeutics 63 PDE4 inhibitor 63 mertansine 63 targeting CD# 63 immatics 63 FGFR 63 novel peptides 63 immunotherapeutics 63 antibody therapeutics 63 MAbs 62 epothilone 62 BiTE 62 MEK inhibitor 62 Factor VIIa 62 Vaccinex 62 BiTE antibody 62 Scancell 62 novel peptide 62 prostone 62 Ambrx 62 Anticalin 62 anticancer compounds 62 Curaxin 62 Symphogen 62 JAK1 62 novel anti infective 62 immunotherapeutic 62 Epitomics 62 biotherapeutics 62 cancer immunotherapy 62 Tranzyme 62 humanized monoclonal antibodies 62 IAP inhibitors 61 G Protein Coupled 61 KineMed 61 Nanobodies 61 monoclonal 61 JAK inhibitors 61 NTDDS 61 mAbs 61 siRNA therapeutic 61 oncolytic 61 antisense drug 61 PEGylated 61 AEG# 61 Stapled Peptide 61 XmAb 61 human monoclonal antibody 61 ESBA# 61 rxRNA 61 Archexin 61 IMC #B 61 UltiMAb 61 PsychoGenics 61 Tarvacin TM 61 FoldRx 60 investigational humanized monoclonal antibody 60 novel antibody therapeutics 60 therapeutic proteins 60 ImmunoGen 60 Plexxikon 60 MAb 60 Nanobodies ® 60 Intellikine 60 ANG# 60 MorphoSys 60 epothilones 60 tiapamil 60 histone deacetylase HDAC inhibitors 60 HspE7 60 HuCAL antibody 60 P#X# 60 Tolerx 60 targeted radiotherapeutic 60 OGeS 60 Semafore 60 Micromet BiTE 60 nanoviricides 60 Astex 60 CD# CEA 60 EndoTAG TM 60 humanized antibodies 60 MorphoSys proprietary 60 CD# monoclonal antibody 60 CD# antibody [001] 60 RhuDex ® 60 EndoTAG TM -1 60 polymerase inhibitors 60 anticancer therapeutics 60 recombinant antibodies 60 nicotinic alpha 7 60 Fc fusion protein 60 outlicensing 60 A3 adenosine receptor 60 stem cell therapeutics 60 DOS# 60 OncoVEX GM CSF 60 proteasome inhibitor 59 novel anticancer 59 immunotherapy 59 polyclonal antibodies 59 Anaphore 59 MEK inhibitors 59 oncology therapeutics 59 ddRNAi 59 fusion proteins 59 JAK2 inhibitor 59 polyclonal antibody 59 Phylomer ® 59 ChemoCentryx 59 JAK inhibitor 59 immunotherapies 59 oncology indications 59 Ablynx 59 ALN VSP 59 biomarker discovery 59 PORxin TM 59 Zacharon 59 Lpath 59 SAR# [002] 59 ENMD # 59 Jennerex 59 HCD# [002] 59 Pancreate 59 orally bioavailable 59 Helix BioMedix 59 aptamers 59 RNA antagonist 59 prophylactic vaccines 59 VitiGam 59 IMA# 59 Anticalin R 59 drug conjugate 59 ARIUS 59 Hsp# inhibition 59 NEUGENE 59 anti CD3 monoclonal 59 IND enabling 59 Ceflatonin 59 romazarit 59 TLR Therapeutics 59 Bicifadine 59 anti CD# antibody 59 BioWa 59 cancer therapeutics 59 vascular disrupting agents 59 isoform selective 59 CCR9 antagonist 59 Aurora kinase 59 biotherapeutic 59 Graffinity 59 adrenergic regulation 59 Adenosine Therapeutics 59 AGS PSCA 59 recombinant factor VIIa 59 XmAb ® 59 Myocet 59 recombinant protein 59 Sangamo ZFP technology 59 dAbs 59 kinase inhibitor 59 anti CD3 59 Medarex UltiMAb R 59 OncoMed 59 small molecule inhibitors 59 protein therapeutics 59 developing TB4 58 ASONEP 58 POTELLIGENT R Technology 58 huC# DM4 58 investigational therapies 58 Homspera 58 HuMax CD# 58 Regado 58 Bezielle 58 MAXY G# 58 Ceregene 58 PLK1 SNALP 58 Nektar PEGylation technology 58 molecularly targeted 58 ATL# [001] 58 AVP #D# 58 MT#/MEDI-# 58 pharmacological chaperone 58 RGB # 58 DXL# 58 LY# [003] 58 EndoTAG 58 AVEO 58 Onconase 58 antibody fragment 58 Fleximer 58 Cylene 58 Archemix 58 AQ4N 58 VEGF receptor 58 Receptors GPCRs 58 Tarvacin 58 Marqibo TM 58 tubulin inhibitor 58 proprietary phage display 58 Symadex 58 Relypsa 58 VisEn 58 Zenyaku Kogyo 58 diagnostic biomarkers 58 Aganocide ® 58 PROfusion 58 BHT DNA 58 NEUMUNE 58 antibody therapies 58 kinase inhibitors 58 TapImmune 58 HSP# inhibitor 58 bispecific antibody 58 PXD# 58 oral antiviral 58 OXi# 58 HyACT 58 BioFocus 58 biologic therapeutics 58 BAY #-# 58 CCX# 58 talactoferrin 58 UltiMAb ® 58 antiviral compounds 58 IgG1 antibody 58 Viprovex TM 58 Angiocept 58 IAP inhibitor 58 HuCAL 58 B lymphocyte stimulator 58 Scil Proteins 58 Kosan dependence 58 DPX Survivac 58 chemical entities NCEs 58 NPC 1C 58 IMC A# 58 immunomodulator 58 Anticalins R 58 drug conjugate ADC 58 BioFocus DPI 58 GLPG# 58 OMP #M# 58 BCR ABL inhibitors 58 AtuRNAi 58 XmAb# 58 HuLuc# 58 clinically validated targets 58 anticancer therapies 58 targeted antifolate 58 protein kinase inhibitors 58 anti infective 58 Mersana 58 Regulus Therapeutics 58 ANAVEX 58 antibody MAb 58 PDE# 58 TLR9 agonist 58 commercialize microRNA 58 prodrugs 58 Vegenics 58 Immunogen 57 Xencor 57 humanized anti 57 MT# MEDI 57 TKB# 57 Onalta 57 Antibody 57 nitric oxide donating 57 GRN# 57 CYC# 57 ALN PCS 57 Nautilus Biotech 57 M2 subunit 57 Hybridon 57 T DM1 57 fusion inhibitor 57 siRNA delivery 57 Aegera 57 eniluracil 57 Novosom 57 Zolinza 57 CORT # 57 novel immunomodulatory 57 Sym# 57 AnaptysBio 57 VistaGen 57 Affilin ® 57 chimeric monoclonal antibody 57 mitogen activated ERK kinase 57 preclinically 57 chemically modified siRNA 57 TLR8 57 HCV protease inhibitor 57 poly ADP ribose polymerase 57 PEG SN# 57 Panzem 57 preclinical compounds 57 Insegia 57 recombinant polyclonal antibody 57 Receptos 57 Atiprimod 57 Prednisporin 57 ALN TTR 57 SAR# [004] 57 Carfilzomib 57 AP# [003] 57 AFFiRiS 57 Solazed TM 57 Allovectin 7 R 57 Traficet EN 57 investigational monoclonal antibody 57 histone deacetylase HDAC 57 biologic therapies 57 Juvaris 57 HIV integrase inhibitors 57 GRNVAC1 57 phage display 57 Phylogica 57 Guanilib 57 Pervasis 57 MOR# 57 siRNA 57 ATL# [002] 57 Shigamabs ® 57 Nanobodies R 57 humanized monoclonal 57 Morphotek 57 Exelixis compounds 57 FLT3 57 Aganocide 57 GlycoPEG GCSF 57 TKM ApoB 57 investigational compounds 57 immunological diseases 57 CEQ# 57 otelixizumab 57 oncology 57 Aurora kinase inhibitor 57 XmAb ™ 57 monoclonal antibody therapeutics 57 protein kinase inhibitor 57 OvaRex R 57 investigational pan BCR 57 Iluvien ® 57 SIMPLE Antibody TM 57 antisense 57 MVA BN 57 THR beta agonist 57 HQK 57 TELINTRA 57 PLX# 57 Mpex 57 therapeutic peptide 57 Galenea 57 tyrosine kinase inhibitor 57 Azedra 57 Therapeutic antibodies 57 PER.C6 ® 57 Neurimmune 57 HGS ETR1 57 OncoVEX 57 PDE# inhibitors 57 EP #R 57 Chemokine Therapeutics 57 ZFP TF 57 Personalized Immunotherapy 57 oral prodrug 57 Campath ® 57 HCV polymerase inhibitor 57 anticoagulant reversing agent 57 proteasome inhibitors 57 recombinant biopharmaceutical 57 PSMA ADC 57 Pradefovir 57 Pralatrexate 57 glucokinase activator 57 Chemokine 57 EGEN 57 Litx 57 Inotek 57 Avila Therapeutics 57 Exherin TM 57 Proxinium TM 57 angiogenesis inhibitor 57 SECTA therapy 57 Euroscreen 57 Prodarsan ® 57 Mipomersen 57 Loramyc R 57 YONDELIS 57 Gemin X 57 Intarcia 57 Evotec 57 Epizyme 57 Diatos 57 Pepducin 57 Goserelin 57 GeneICE 57 delta isoform 57 molecular chaperone 57 TLR9 agonists 57 KaloBios 56 FivePrime 56 molecular imaging radiopharmaceuticals 56 RECOTHROM R 56 Daclizumab 56 CR# vcMMAE 56 HIV integrase inhibitor 56 multi kinase inhibitor 56 pradefovir 56 investigational antibody 56 diagnostic molecular imaging 56 Onalta TM 56 chimeric antibodies 56 ErbB3 56 aptamer therapeutics 56 Vicinium TM 56 Kyowa Hakko Kirin 56 SARMs 56 Metabolex 56 PI3K inhibitors 56 dacetuzumab 56 oncolytic virus therapies 56 VentiRx 56 anti CD# antibodies 56 Accelerated Intelligent 56 ActivX 56 #D#C# 56 Clavis Pharma 56 NanoViricides 56 biosurgical 56 5 HT6 56 Minapharm 56 PARP inhibitor 56 predictive biomarkers 56 NOXXON 56 TKM PLK1 56 POTELLIGENT ® 56 Heptares 56 HCV NS3 protease 56 Oncaspar 56 engineered RAP peptides 56 Idera Pharmaceuticals 56 Chrysalin 56 Janus Kinase 56 Quark Pharmaceuticals 56 Zemiva TM 56 bispecific 56 GPR# agonist 56 monoclonal antibody mAb 56 CXCR4 receptor 56 systemic RNAi 56 Trofex 56 HDACi 56 vaccines oncolytic virus 56 adenoviral 56 HCV polymerase 56 Poly ICR 56 novel immunotherapeutic 56 HepDirect 56 PRT# 56 Chimigen TM 56 Homspera TM 56 NEUGENE R 56 Nexavar ® 56 Viventia 56 short interfering RNA 56 HSP# inhibitors 56 Blinatumomab 56 topical anti infective 56 Ophthotech 56 IgG1 monoclonal antibody 56 CB2 selective 56 TOPIGEN 56 novel RNAi therapeutics 56 selective kinase inhibitor 56 zanolimumab 56 AKIP 56 NexACT 56 ExonHit 56 Onalta ™ 56 Locked Nucleic Acid 56 belinostat 56 NNRs 56 anticancer agent 56 intranasal delivery 56 PNP inhibitor 56 platforms GVAX 56 Micromet proprietary BiTE 56 trastuzumab DM1 T DM1 56 Peregrine Pharmaceuticals 56 IGN# 56 Protexia R 56 Applied NeuroSolutions 56 DsiRNA 56 CYT# potent vascular disrupting 56 small molecule modulators 56 Annamycin 56 Lixivaptan 56 DNA plasmids 56 INxin TM 56 ganetespib 56 bafetinib 56 Allovectin 7 56 Charlesson 56 Viamet 56 AMPK activators 56 BioSeek 56 therapeutic mAbs 56 TÎ ² 4 56 ETBs 56 GAP #B# 56 monoclonal antibodies MAbs 56 PI3K/mTOR 56 polyclonal 56 thymalfasin 56 Dicer Substrate Technology 56 HuMax CD4 56 Monoclonal Antibody 56 LentiVector technology 56 SNALP 56 hematological cancers 56 companion diagnostics 56 photodisinfection 56 DiscoveRx 56 InterfeRx 56 antibodies 56 Quark Biotech 56 Domantis 56 ALN TTR# 56 small molecule thrombopoietin 56 Hsp# inhibitors 56 therapeutic 56 exon skipping 56 Merrimack Pharmaceuticals 56 LEAPS TM 56 AVE# 56 generation antisense 56 novel therapeutic antibodies 56 Curaxins 56 Serdaxin 56 Mycograb 56 biobetter 56 elbion 56 immune stimulatory 56 ZEVALIN ® 56 InNexus Biotechnology 56 methylnaltrexone 56 recombinant subunit vaccine 56 entinostat 56 immunotoxin 56 antisense oligonucleotides 56 MOZOBIL 56 MMAE 56 Pertuzumab 56 RNAi therapeutic targeting 56 PEGylation technology 56 Hsp# inhibitor 56 INT# [002] 56 HGS# 56 Phase IIb clinical trials 55 cilengitide 55 XL# XL# 55 DAVANAT R 55 Affitech 55 Anticalins 55 preclinical toxicology 55 GPCR 55 IRX 2 55 QuatRx 55 aptamer 55 pan HDAC inhibitor 55 shRNA libraries 55 Celator 55 vaccine GRNVAC1 55 Aviptadil 55 MacroGenics 55 Apexigen 55 Cethrin R 55 OMP #R# 55 prostate cancer antigen prostatic 55 Lycera 55 PORxin TM platforms 55 ImmunoGen Inc. 55 synthetic peptides 55 dAb 55 New Chemical Entities 55 teplizumab 55 LFRP 55 p# inhibitors 55 biased ligand 55 HuMax 55 Factor IX 55 therapeutic peptides 55 Exelixis XL# 55 depsipeptide 55 Radilex 55 Santaris 55 peptide antigens 55 receptor tyrosine kinase inhibitor 55 NITD 55 telomerase therapeutic 55 Debio 55 RAV# 55 XL# XL# XL# XL# 55 allosteric modulators 55 MGCD# [001] 55 Epothilones 55 NNR Therapeutics 55 HepeX B 55 delivered RNAi therapeutic 55 oncolytic viruses 55 Metabasis 55 PRX# 55 immunomodulatory 55 oncolytic virus therapy 55 Pimavanserin 55 AKIP ™ 55 Sphingomab 55 BioInvent 55 Drug Repositioning 55 Biovitrum 55 GPCR targets 55 PI3K inhibitor 55 MORAb 55 PRLX # 55 renin inhibitors 55 obatoclax 55 HistoRx 55 Catalyst Biosciences 55 VEGF Trap 55 Trofex TM 55 Interferon alpha 55 Aerosurf 55 ImmunGene 55 non nucleoside HCV 55 anti infective treatments 55 Civacir 55 SR Pharma 55 Bioral 55 disease modifying 55 Anacor 55 synthetic retinoid 55 Tumour Vascular Disrupting Agent 55 URG# 55 novel antiviral therapeutics 55 NKTR 55 oral kinase inhibitor 55 Vilazodone 55 HCV protease inhibitors 55 rxRNA compounds 55 Protectan CBLB# 55 Serenex 55 Aplidin 55 Pentad TM 55 prophylactic vaccine 55 4SC AG 55 ApoB SNALP 55 Maxy G# 55 GVAX cancer 55 Karo Bio 55 arGEN X 55 DuraSite 55 DermaPrep 55 DepoVax 55 ALTROPANE 55 POTELLIGENT R 55 CHDI 55 Alpharadin 55 KNS # 55 radionuclide therapy 55 GammaCan 55 MDRNA proprietary 55 TG# [003] 55 Nasdaq HALO biopharmaceutical 55 Intellect Neurosciences 55 Ecallantide 55 KSP inhibitor 55 Ridaforolimus 55 Triolex 55 CB2 selective receptor agonist 55 LymphoStat B 55 HCV protease 55 SERMs 55 Affimed 55 EnVivo Pharmaceuticals 55 DeveloGen 55 Metallophile ™ Technology 55 Aurora Kinase 55 ionotropic glutamate receptor antagonists 55 metaglidasen 55 selective immunoproteasome inhibitor 55 Dapagliflozin 55 MKC# MT 55 EnVivo 55 Bioral Amphotericin B. 55 ProNAi 55 LEX System 55 CD3 monoclonal antibody 55 Hemopurifier 55 IMGN# 55 atacicept 55 PI3 kinase 55 Taligen 55 Sorrento Therapeutics 55 Dyax phage display 55 SinuNase ™ 55 LNP formulations 55 antitumoral 55 Xencor XmAb 55 GED aPC 55 XmAb TM 55 Maribavir 55 cartilage regeneration 55 Achaogen 55 midstage trials 55 Golimumab 55 Bavituximab 55 tumor antigens 55 ALK inhibitor 55 AAG geldanamycin analog 55 lipid nanoparticle 55 Cempra 55 cleavable linker 55 orally dosed 55 inhibit EGFR 55 MCSP respectively 55 NovaBay 55 Janus kinase 55 alpha folate receptor 55 Addrenex 55 iPSC technology 55 HDAC 55 PulmoScience 55 Octreotide 55 KemPharm 55 GLP toxicology studies 55 GSK # 55 Aeolus Pharmaceuticals 55 HCV antiviral 55 HDAC inhibitor 55 CombinatoRx 55 vascular disrupting agent 55 Excellarate 55 FluCide 55 oncolytic virus 55 Santaris Pharma 55 CellCentric 55 Ligand 55 HepDirect technology 55 Ibis Biosciences 55 antibody fragments 55 INS# [001] 55 GPCRs 55 Intravenous Human 55 Cethromycin 55 R#/MEM # 55 antiviral therapeutics 55 Isogenica 55 Preclinical studies suggest 55 PEGylation 55 TACI Ig 55 prodrug 55 MKC# MKC# PP 55 drug pipeline TAFA# 55 L DOS# 55 Phenoxodiol 55 mitotic kinesin 55 HER2/neu 55 OncoVex 55 ZFP TFs 55 Amunix 55 anti amnesic 55 recombinant vaccine 55 Syntonix 55 ophthalmology oncology 55 orally administered inhibitor 55 Addex Pharmaceuticals www.addexpharma.com discoverMunsif Khan spokesman 55 defensin mimetic antibiotic 55 Anticalins ® 55 Nuron Biotech 55 Versartis 55 DAVANAT 55 microRNA therapeutics 55 synthetic siRNA 55 enzastaurin 55 Ceflatonin R 55 Eligard R 55 anti EGFR antibody 55 MLN# 54 Avicena 54 Syndax 54 Lpathomab 54 PARP inhibitors 54 4SC 54 oral proteasome inhibitor 54 recombinant adeno associated 54 AVN# [001] 54 ERYtech Pharma 54 InNexus 54 Squalamine 54 Evotec OAI 54 fusion protein 54 muscarinic receptor agonist 54 NS5A 54 NovImmune 54 NovaBay Aganocide compounds 54 MDV# 54 vaccine adjuvant 54 NXL# 54 chemotherapy induced neutropenia 54 Onconova 54 human antibody therapeutics 54 oral taxane 54 Prodarsan R 54 ADCC enhanced 54 Radezolid 54 liposomal delivery 54 taxane 54 Affibody ® molecules 54 anti CD3 antibody 54 ErbB3 HER3 54 P#X# antagonist 54 targeted radiotherapeutics 54 GlycArt 54 trastuzumab Herceptin 54 antibody fragment therapeutics 54 HepDirect R 54 histone deacetylase inhibitor 54 peptides 54 selectively inhibit 54 Portola Pharmaceuticals 54 personalized immunotherapy 54 NP2 Enkephalin 54 Locked Nucleic Acid LNA 54 biased ligands 54 sigma receptors 54 Dalbavancin 54 molecular imaging radiopharmaceutical 54 Potelligent Technology 54 ARRY # 54 Can Fite 54 StromaCel Inc. 54 delta opioid receptor 54 anti CD# monoclonal 54 cannabinor 54 RNA interference RNAi therapeutics 54 Opexa 54 FASgen 54 XOMA 3AB 54 BiTE R 54 Cintredekin Besudotox 54 Tß4 54 KuDOS 54 bardoxolone 54 selective androgen receptor modulators 54 ABL inhibitor 54 Anticalin ® 54 CA4P 54 Promedior 54 Oasmia 54 Protexia ® 54 Suven 54 Tyrima 54 anticancer agents 54 OXIGON TM 54 antisense oligonucleotide 54 Targeted Chemotherapy 54 Syrrx 54 liposomal 54 engineered proteases 54 mTOR inhibitors 54 synthetic peptide 54 HuCAL antibodies 54 ESBATech 54 neuraminidase inhibitor 54 Eg5 54 elotuzumab 54 IMiDs R 54 RNAi therapeutics 54 RNAi 54 ArQule Kinase Inhibitor Platform 54 tafamidis 54 novel therapeutics 54 Crofelemer 54 Veronate 54 biologics 54 GENFIT 54 active cellular immunotherapy 54 Caprion 54 RNA therapeutics 54 ImmunoGen TAP technology 54 Leukine ® 54 darinaparsin ZIO 54 HER2 receptor 54 JAK#/JAK# 54 Protein Kinase C 54 Tarvacin Anti Viral 54 antitumor 54 Azixa 54 FoldRx Pharmaceuticals Inc. 54 Virulizin R 54 Virulizin ® 54 TGR5 54 TGF Beta 54 telomerase activators 54 Trophos 54 hormone gastrin 54 CDP# 54 FAAH 54 HepaGam B 54 ocular formulation 54 VelocImmune 54 Solazed 54 cathepsin K inhibitor 54 Anti angiogenic 54 tranilast 54 dSLIM 54 virosome 54 HAAH 54 ChemDiv 54 accumulate preferentially 54 TG# [001] 54 injectable formulation 54 CB2 receptor 54 histone deacetylase HDAC inhibitor 54 sd rxRNA 54 Aptamer 54 HepaLife 54 Lupuzor 54 gefitinib Iressa 54 Herceptin trastuzumab 54 Synavive 54 GlycoPEGylated hemostasis compounds 54 Immunotherapeutic 54 reformulates existing FDA 54 HER1 54 PKC# 54 Hollis Eden 54 Desmoteplase 54 pDNA vaccines 54 Vion Pharmaceuticals 54 Azedra TM 54 Aurexis 54 antisense inhibitors 54 Amplimexon 54 AcelRx 54 VisEn Medical 54 Presidio Pharmaceuticals 54 PGL# 54 SinuNase TM 54 epigenetic enzymes 54 monoclonal anti 54 CD# expressing 54 vemurafenib 54 Interferon alfa 54 XenoMouse 54 topical dermatology 54 Synavive ™ 54 Wnt signaling pathway 54 Stemgent 54 dependent cellular cytotoxicity 54 glycosylation profile 54 Anthim 54 Medarex UltiMAb 54 anti botulism antibody 54 Romidepsin 54 ThromboGenics 54 proprietary PEGylation 54 SCIB1 54 deforolimus 54 Crucell PER.C6 ® 54 RayBiotech 54 transfection reagents 54 glycosylated 54 Ore Pharmaceuticals 54 outlicense 54 Factor VIIa Factor VIII